The University of Southampton
University of Southampton Institutional Repository

The DNMT3B C?T promoter polymorphism and risk of breast cancer in a British population: a case-control study

The DNMT3B C?T promoter polymorphism and risk of breast cancer in a British population: a case-control study
The DNMT3B C?T promoter polymorphism and risk of breast cancer in a British population: a case-control study
Background: gene promoter methylation is an important regulator of expression and is a key epigenetic factor in tumorigenesis. DNA methylation is mediated by DNA methyltransferases (DNMTs), of which three active forms have been identified: DNMT1, DNM3A and DNMT3B. The C?T transition polymorphism (C46359T) in the promoter of the DNMT3B gene, which significantly increases transcriptional activity, has been postulated to increase the propensity for promoter-hypermethylation-mediated silencing of tumour suppressor genes.
Methods: to determine the role of this polymorphism in breast cancer, we genotyped 352 cases and 258 controls from a British population. The breast cancer cases were selected on the basis of either an age at onset of less than 40 years, a family history of breast cancer irrespective of age at onset, or bilateral breast cancer diagnosed after 39 years of age irrespective of family history.
Results: the C allele was found to be more common in case subjects than in control subjects (cases, 0.59; controls, 0.54) corresponding to a nominally significant increase in breast cancer risk to heterozygotes and CC homozygotes (odds ratio 1.51, 95% confidence interval 1.01–2.25) in the dominant inheritance model.
Conclusions: our findings contrast with those of a previous study, which showed that individuals carrying at least one T allele have a significantly increased risk of developing lung cancer. This discrepancy might be an artefact resulting from a chance variation, or it might point to differing influences of promoter hypermethylation in these cancer types.
R390-R394
Montgomery, Karen G.
13ec8448-1ba2-4d0b-8d56-4270be80de0b
Liu, Mira C.P.
c68d64b5-86fa-4c38-9e8e-71edb3a52be7
Eccles, Diana M.
5b59bc73-11c9-4cf0-a9d5-7a8e523eee23
Campbell, Ian G.
681789cb-d416-4722-9ba8-449c7af96673
Montgomery, Karen G.
13ec8448-1ba2-4d0b-8d56-4270be80de0b
Liu, Mira C.P.
c68d64b5-86fa-4c38-9e8e-71edb3a52be7
Eccles, Diana M.
5b59bc73-11c9-4cf0-a9d5-7a8e523eee23
Campbell, Ian G.
681789cb-d416-4722-9ba8-449c7af96673

Montgomery, Karen G., Liu, Mira C.P., Eccles, Diana M. and Campbell, Ian G. (2004) The DNMT3B C?T promoter polymorphism and risk of breast cancer in a British population: a case-control study. Breast Cancer Research, 6 (4), R390-R394. (doi:10.1186/bcr807).

Record type: Article

Abstract

Background: gene promoter methylation is an important regulator of expression and is a key epigenetic factor in tumorigenesis. DNA methylation is mediated by DNA methyltransferases (DNMTs), of which three active forms have been identified: DNMT1, DNM3A and DNMT3B. The C?T transition polymorphism (C46359T) in the promoter of the DNMT3B gene, which significantly increases transcriptional activity, has been postulated to increase the propensity for promoter-hypermethylation-mediated silencing of tumour suppressor genes.
Methods: to determine the role of this polymorphism in breast cancer, we genotyped 352 cases and 258 controls from a British population. The breast cancer cases were selected on the basis of either an age at onset of less than 40 years, a family history of breast cancer irrespective of age at onset, or bilateral breast cancer diagnosed after 39 years of age irrespective of family history.
Results: the C allele was found to be more common in case subjects than in control subjects (cases, 0.59; controls, 0.54) corresponding to a nominally significant increase in breast cancer risk to heterozygotes and CC homozygotes (odds ratio 1.51, 95% confidence interval 1.01–2.25) in the dominant inheritance model.
Conclusions: our findings contrast with those of a previous study, which showed that individuals carrying at least one T allele have a significantly increased risk of developing lung cancer. This discrepancy might be an artefact resulting from a chance variation, or it might point to differing influences of promoter hypermethylation in these cancer types.

This record has no associated files available for download.

More information

Published date: 2004

Identifiers

Local EPrints ID: 26489
URI: http://eprints.soton.ac.uk/id/eprint/26489
PURE UUID: b75960cd-9658-4d6e-947a-051969f62120
ORCID for Diana M. Eccles: ORCID iD orcid.org/0000-0002-9935-3169

Catalogue record

Date deposited: 12 Apr 2006
Last modified: 16 Mar 2024 02:39

Export record

Altmetrics

Contributors

Author: Karen G. Montgomery
Author: Mira C.P. Liu
Author: Diana M. Eccles ORCID iD
Author: Ian G. Campbell

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×